Kinex names Michael Murphy director
This article was originally published in Scrip
Executive Summary
Buffalo, New York-based Kinex Pharmaceuticals has named Michael Murphy to its board of directors. In parallel, Dr Jean-Pierre Sommadossi is stepping down from the company's board, but will continue to act as a senior advisor to Kinex's CEO Dr Johnson Lau. Mr Murphy is a senior partner at law firm DLA Piper. He is also a founding member of the private equity and angel investment firm Shadow Rock with holdings in the pharmaceutical, technology, real estate and other sectors. He said as an investor with Kinex he has been "consistently impressed" by the firm which he says has a "strong and impressive pipeline of clinical oncology drug candidates." Mr Murphy is based out of DLA Piper's New York, London and Hong Kong offices.